Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 25Completed 7Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 687INDUSTRY 623NIH 62NETWORK 29OTHER_GOV 5FED 3UNKNOWN 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × UNKNOWN × Thoracic × Clear all
NCT02346955 2020-08-27

MK-6018-001

KitovPharma

Phase 1 Terminated
27 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡